stockrowAdaptive Biotechnologies Corporation (ADPT) vs Personalis, Inc. (PSNL)
- Adaptive Biotechnologies Corporation ADPT 27.43 +2.24%
- Personalis, Inc. PSNL 15.70 +0.96%
Adaptive Biotechnologies Corporation and Personalis, Inc. are both Diagnostics & Research companies. Adaptive Biotechnologies Corporation is the larger, with a market value of $4.3B against $1.7B — 2.5× the size. Adaptive Biotechnologies Corporation grew revenue faster over the last twelve months: 17.9% against 16.9%. Adaptive Biotechnologies Corporation has the higher net margin (−23.7% vs −147.7%) and the higher return on invested capital (0.00% vs −358.4%). Across the 17 metrics below, Adaptive Biotechnologies Corporation leads on 14 and Personalis, Inc. on 3.
Valuation
Profitability
| Metric | ADPT | PSNL | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 74.15% | 16.71% | 48.32% |
| Operating margin | (16.18%) | (156.66%) | (5.68%) |
| Net margin | (23.66%) | (147.74%) | (4.10%) |
| Free cash flow margin | (2.96%) | (120.79%) | 0.00% |
| Return on equity | (36.34%) | (62.14%) | 0.00% |
| Return on assets | (12.02%) | (44.66%) | (6.05%) |
| Return on invested capital | 0.00% | (358.37%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack